This is a community-generated profile. If you would like to claim it, please .
Alnylam Pharmaceuticals
Develops RNAi therapeutics for rare genetic & other diseases501-1000 EmployeesActively Hiring
Alnylam Pharmaceuticals careers
Alnylam is the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare genetic, cardio-metabolic, hepatic infectious, and central nervous system (CNS)/ocular diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach for the treatment of a wide range of severe and debilitating diseases.
Senior Manager, Clinical Data Management
In office • Cambridge
$144k – $195k4 days ago
Manager, CMC Project Management
In office • Cambridge
$109k – $148k4 days ago
Director, Research AI
In office • Cambridge
$193k – $289k6 days ago
Associate Director, Nonclinical Writing AI Innovation
In office • Cambridge
$156k – $211k6 days ago
Cyber Defense Principal Engineer
In office • Cambridge
$199k – $270k1 week ago
Cyber Defense Platforms Staff Engineer
In office • Cambridge
$174k – $235k2 weeks ago
Software Engineer
In office • Cambridge
2 weeks ago
Associate Director, Market Insights
In office • Cambridge
$165k – $224k1 month ago
Assoc Director, CRM Product Owner
In office • Cambridge
$172k – $233k2 months ago
Senior Director, Quality Technology
In office • Cambridge
$226k – $306k2 months ago
David Wood
Director Information Security/Cybersecurity
Akshat Sai
Extensive 10+ years of professional experience in PHP development.
Kenasha Johnson
Total raised
$710M
Funded over
2 rounds
Latest round